The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Pacific Biosciences of California Inc (NASDAQ: PACB) closed at $1.47 in the last session, down -2.00% from day before closing price of $1.5. In other words, the price has decreased by -$2.00 from its previous closing price. On the day, 4.33 million shares were traded. PACB stock price reached its highest trading level at $1.51 during the session, while it also had its lowest trading level at $1.45.
Ratios:
We take a closer look at PACB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.87 and its Current Ratio is at 6.68. In the meantime, Its Debt-to-Equity ratio is 7.63 whereas as Long-Term Debt/Eq ratio is at 7.60.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 19 ’25 when Farmer Michele sold 5,195 shares for $1.00 per share. The transaction valued at 5,200 led to the insider holds 269,259 shares of the business.
HENRY CHRISTIAN O sold 12,497 shares of PACB for $17,583 on Mar 03 ’25. The insider now owns 2,225,357 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Van Oene Mark, who serves as the insider of the company, sold 6,486 shares for $1.41 each. As a result, the insider received 9,126 and left with 1,497,695 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 441124960 and an Enterprise Value of 731105984. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.90 while its Price-to-Book (P/B) ratio in mrq is 4.81. Its current Enterprise Value per Revenue stands at 4.799 whereas that against EBITDA is -3.056.
Stock Price History:
The Beta on a monthly basis for PACB is 2.17, which has changed by -0.0925926 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, PACB has reached a high of $2.72, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 24.68%, while the 200-Day Moving Average is calculated to be -5.34%.
Shares Statistics:
According to the various share statistics, PACB traded on average about 8.96M shares per day over the past 3-months and 9907390 shares per day over the past 10 days. A total of 300.04M shares are outstanding, with a floating share count of 264.16M. Insiders hold about 11.97% of the company’s shares, while institutions hold 65.85% stake in the company. Shares short for PACB as of 1749772800 were 39640882 with a Short Ratio of 5.29, compared to 1747267200 on 56947935. Therefore, it implies a Short% of Shares Outstanding of 39640882 and a Short% of Float of 15.03.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
